Fidelity Investments
AVXL icon

Fidelity Investments’s Anavex Life Sciences AVXL Stock Holding History

Fidelity Investments’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155K Buy
60,024
+51,529
+607% +$152K ﹤0.01% 3777
2026
Q1 		$26.1K Sell
8,495
-5,934
-41% -$25.7K ﹤0.01% 4412
2025
Q4 		$51.4K Buy
14,429
+3,824
+36% +$23.4K ﹤0.01% 4099
2025
Q3 		$94.4K Buy
10,605
+195
+2% +$1.98K ﹤0.01% 3690
2025
Q2 		$96K Buy
10,410
+114
+1% +$973 ﹤0.01% 3622
2025
Q1 		$88.3K Buy
10,296
+1,368
+15% +$12.9K ﹤0.01% 3612
2024
Q4 		$95.9K Buy
8,928
+526
+6% +$4.05K ﹤0.01% 3564
2024
Q3 		$47.7K Sell
8,402
-4,884
-37% -$28.2K ﹤0.01% 3802
2024
Q2 		$56.1K Buy
13,286
+11,541
+661% +$46.7K ﹤0.01% 3557
2024
Q1 		$8.88K Sell
1,745
-7,502
-81% -$42.2K ﹤0.01% 4324
2023
Q4 		$86.1K Buy
9,247
+8,396
+987% +$57.8K ﹤0.01% 3275
2023
Q3 		$5.57K Sell
851
-1,111
-57% -$8.84K ﹤0.01% 4300
2023
Q2 		$16K Buy
1,962
+562
+40% +$4.82K ﹤0.01% 3964
2023
Q1 		$12K Buy
1,400
+338
+32% +$3.37K ﹤0.01% 4057
2022
Q4 		$9.84K Sell
1,062
-637
-37% -$6.8K ﹤0.01% 4020
2022
Q3 		$17K Sell
1,699
-44,346
-96% -$468K ﹤0.01% 3904
2022
Q2 		$461K Buy
46,045
+298
+0.7% +$2.82K ﹤0.01% 2873
2022
Q1 		$563K Buy
45,747
+45,710
+123,541% +$562K ﹤0.01% 2948
2021
Q4 		$1K Sell
37
-2,500
-99% -$47.5K ﹤0.01% 4093
2021
Q3 		$46K Buy
2,537
+2,492
+5,538% +$49.6K ﹤0.01% 3231
2021
Q2 		$1K Buy
+45
New +$666 ﹤0.01% 3994

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fidelity Investments's AVXL Position: Q2 2026 in Review

Fidelity Investments increased its Anavex Life Sciences (AVXL) stake by 607% in Q2 2026, buying an estimated $152K and bringing the position to 60,024 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #3777.

Fidelity Investments first reported a position in AVXL in Q2 2021 and has held it in 21 quarters since. The position peaked at $563K in Q1 2022. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Fidelity Investments held 60,024 shares of Anavex Life Sciences worth $155K as of Q2 2026.
  • Fidelity Investments bought 51,529 Anavex Life Sciences shares in Q2 2026, an estimated $152K.
  • Anavex Life Sciences made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3777 holding.
  • Fidelity Investments first reported a position in Anavex Life Sciences in Q2 2021 and has held it in 21 quarters since.
  • Fidelity Investments's Anavex Life Sciences position peaked at $563K in Q1 2022.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.